| Description | Amflutizole used for the treatment of gout, and is a Xanthine oxidase inhibitor |
| In vivo | Amflutizole is a xanthine oxidase inhibitor, inhibits free radical generation in the ischemic/reperfused rat cerebral cortex[1] |
| molecular weight | 288.246 |
| Molecular formula | C11H7F3N2O2S |
| CAS | 82114-19-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 2.88 mg/mL (10 mM) |
| References | 1. Phillis J W , Sen S , Cao X . Amflutizole, a xanthine oxidase inhibitor, inhibits free radical generation in the ischemic/reperfused rat cerebral cortex[J]. Neuroence Letters, 1994, 169(1):188-190. 2. M H O'Regan 1 , M Smith-Barbour, L M Perkins. et al.The effect of amflutizole, a xanthine oxidase inhibitor, on ischemia-evoked purine release and free radical formation in the rat cerebral cortex.Neuropharmacology. 1994 Oct;33(10):1197-201. |